Report Details

Protein-based Drug Market, Global Outlook and Forecast 2023-2029

ID : PRR-421272
Date : 2023-11-23
Pages : 147
Industry : Pharmaceutical and Healthcare

This research report provides a comprehensive analysis of the Protein-based Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Protein-based Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Protein-based Drug, challenges faced by the industry, and potential opportunities for market players.
The global Protein-based Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Protein-based Drug market presents opportunities for various stakeholders, including Immune Diseases, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Protein-based Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Protein-based Drug market was valued at US$ 203180 million in 2022 and is projected to reach US$ 407540 million by 2029, at a CAGR of 10.5% during the forecast period.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
Key Features:
The research report on the Protein-based Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Protein-based Drug market.
Market Overview: The report provides a comprehensive overview of the Protein-based Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type e.g., Antibody-based Drugs, Fc Fusion Proteins, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Protein-based Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Protein-based Drug markets trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Protein-based Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Protein-based Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Protein-based Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Protein-based Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Protein-based Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Protein-based Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Protein-based Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antibody-based Drugs
Fc Fusion Proteins
Anticoagulants
Blood Factors
Other
Market segment by Application
Immune Diseases
Cancer
Other
Global Protein-based Drug Market Segment Percentages, By Region and Country, 2022 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Sanofi
Sobi
Kanghong Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein-based Drug, market overview.
Chapter 2: Global Protein-based Drug market size in revenue.
Chapter 3: Detailed analysis of Protein-based Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein-based Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Protein-based Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein-based Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein-based Drug Overall Market Size
2.1 Global Protein-based Drug Market Size: 2022 VS 2029
2.2 Global Protein-based Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Protein-based Drug Players in Global Market
3.2 Top Global Protein-based Drug Companies Ranked by Revenue
3.3 Global Protein-based Drug Revenue by Companies
3.4 Top 3 and Top 5 Protein-based Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Protein-based Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Protein-based Drug Players in Global Market
3.6.1 List of Global Tier 1 Protein-based Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Protein-based Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Protein-based Drug Market Size Markets, 2022 & 2029
4.1.2 Antibody-based Drugs
4.1.3 Fc Fusion Proteins
4.1.4 Anticoagulants
4.1.5 Blood Factors
4.1.6 Other
4.2 By Type - Global Protein-based Drug Revenue & Forecasts
4.2.1 By Type - Global Protein-based Drug Revenue, 2018-2023
4.2.2 By Type - Global Protein-based Drug Revenue, 2024-2029
4.2.3 By Type - Global Protein-based Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Protein-based Drug Market Size, 2022 & 2029
5.1.2 Immune Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Protein-based Drug Revenue & Forecasts
5.2.1 By Application - Global Protein-based Drug Revenue, 2018-2023
5.2.2 By Application - Global Protein-based Drug Revenue, 2024-2029
5.2.3 By Application - Global Protein-based Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Protein-based Drug Market Size, 2022 & 2029
6.2 By Region - Global Protein-based Drug Revenue & Forecasts
6.2.1 By Region - Global Protein-based Drug Revenue, 2018-2023
6.2.2 By Region - Global Protein-based Drug Revenue, 2024-2029
6.2.3 By Region - Global Protein-based Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Protein-based Drug Revenue, 2018-2029
6.3.2 US Protein-based Drug Market Size, 2018-2029
6.3.3 Canada Protein-based Drug Market Size, 2018-2029
6.3.4 Mexico Protein-based Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Protein-based Drug Revenue, 2018-2029
6.4.2 Germany Protein-based Drug Market Size, 2018-2029
6.4.3 France Protein-based Drug Market Size, 2018-2029
6.4.4 U.K. Protein-based Drug Market Size, 2018-2029
6.4.5 Italy Protein-based Drug Market Size, 2018-2029
6.4.6 Russia Protein-based Drug Market Size, 2018-2029
6.4.7 Nordic Countries Protein-based Drug Market Size, 2018-2029
6.4.8 Benelux Protein-based Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Protein-based Drug Revenue, 2018-2029
6.5.2 China Protein-based Drug Market Size, 2018-2029
6.5.3 Japan Protein-based Drug Market Size, 2018-2029
6.5.4 South Korea Protein-based Drug Market Size, 2018-2029
6.5.5 Southeast Asia Protein-based Drug Market Size, 2018-2029
6.5.6 India Protein-based Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Protein-based Drug Revenue, 2018-2029
6.6.2 Brazil Protein-based Drug Market Size, 2018-2029
6.6.3 Argentina Protein-based Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Protein-based Drug Revenue, 2018-2029
6.7.2 Turkey Protein-based Drug Market Size, 2018-2029
6.7.3 Israel Protein-based Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Protein-based Drug Market Size, 2018-2029
6.7.5 UAE Protein-based Drug Market Size, 2018-2029
7 Protein-based Drug Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Protein-based Drug Major Product Offerings
7.1.4 AbbVie Protein-based Drug Revenue in Global Market 2018-2023
7.1.5 AbbVie Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Protein-based Drug Major Product Offerings
7.2.4 Johnson & Johnson Protein-based Drug Revenue in Global Market 2018-2023
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Protein-based Drug Major Product Offerings
7.3.4 Novartis Protein-based Drug Revenue in Global Market 2018-2023
7.3.5 Novartis Key News & Latest Developments
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Protein-based Drug Major Product Offerings
7.4.4 Gilead Sciences Protein-based Drug Revenue in Global Market 2018-2023
7.4.5 Gilead Sciences Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Protein-based Drug Major Product Offerings
7.5.4 Roche Protein-based Drug Revenue in Global Market 2018-2023
7.5.5 Roche Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Protein-based Drug Major Product Offerings
7.6.4 Bristol-Myers Squibb Protein-based Drug Revenue in Global Market 2018-2023
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Amgen
7.7.1 Amgen Company Summary
7.7.2 Amgen Business Overview
7.7.3 Amgen Protein-based Drug Major Product Offerings
7.7.4 Amgen Protein-based Drug Revenue in Global Market 2018-2023
7.7.5 Amgen Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Protein-based Drug Major Product Offerings
7.8.4 AstraZeneca Protein-based Drug Revenue in Global Market 2018-2023
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Merck & Co
7.9.1 Merck & Co Company Summary
7.9.2 Merck & Co Business Overview
7.9.3 Merck & Co Protein-based Drug Major Product Offerings
7.9.4 Merck & Co Protein-based Drug Revenue in Global Market 2018-2023
7.9.5 Merck & Co Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Protein-based Drug Major Product Offerings
7.10.4 Takeda Protein-based Drug Revenue in Global Market 2018-2023
7.10.5 Takeda Key News & Latest Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Company Summary
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Protein-based Drug Major Product Offerings
7.11.4 Merck KGaA Protein-based Drug Revenue in Global Market 2018-2023
7.11.5 Merck KGaA Key News & Latest Developments
7.12 Seagen
7.12.1 Seagen Company Summary
7.12.2 Seagen Business Overview
7.12.3 Seagen Protein-based Drug Major Product Offerings
7.12.4 Seagen Protein-based Drug Revenue in Global Market 2018-2023
7.12.5 Seagen Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Protein-based Drug Major Product Offerings
7.13.4 Eli Lilly Protein-based Drug Revenue in Global Market 2018-2023
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Company Summary
7.14.2 Ono Pharmaceutical Business Overview
7.14.3 Ono Pharmaceutical Protein-based Drug Major Product Offerings
7.14.4 Ono Pharmaceutical Protein-based Drug Revenue in Global Market 2018-2023
7.14.5 Ono Pharmaceutical Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Protein-based Drug Major Product Offerings
7.15.4 Pfizer Protein-based Drug Revenue in Global Market 2018-2023
7.15.5 Pfizer Key News & Latest Developments
7.16 Regeneron
7.16.1 Regeneron Company Summary
7.16.2 Regeneron Business Overview
7.16.3 Regeneron Protein-based Drug Major Product Offerings
7.16.4 Regeneron Protein-based Drug Revenue in Global Market 2018-2023
7.16.5 Regeneron Key News & Latest Developments
7.17 Innovent
7.17.1 Innovent Company Summary
7.17.2 Innovent Business Overview
7.17.3 Innovent Protein-based Drug Major Product Offerings
7.17.4 Innovent Protein-based Drug Revenue in Global Market 2018-2023
7.17.5 Innovent Key News & Latest Developments
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Company Summary
7.18.2 Hengrui Medicine Business Overview
7.18.3 Hengrui Medicine Protein-based Drug Major Product Offerings
7.18.4 Hengrui Medicine Protein-based Drug Revenue in Global Market 2018-2023
7.18.5 Hengrui Medicine Key News & Latest Developments
7.19 Sanofi
7.19.1 Sanofi Company Summary
7.19.2 Sanofi Business Overview
7.19.3 Sanofi Protein-based Drug Major Product Offerings
7.19.4 Sanofi Protein-based Drug Revenue in Global Market 2018-2023
7.19.5 Sanofi Key News & Latest Developments
7.20 Sobi
7.20.1 Sobi Company Summary
7.20.2 Sobi Business Overview
7.20.3 Sobi Protein-based Drug Major Product Offerings
7.20.4 Sobi Protein-based Drug Revenue in Global Market 2018-2023
7.20.5 Sobi Key News & Latest Developments
7.21 Kanghong Pharma
7.21.1 Kanghong Pharma Company Summary
7.21.2 Kanghong Pharma Business Overview
7.21.3 Kanghong Pharma Protein-based Drug Major Product Offerings
7.21.4 Kanghong Pharma Protein-based Drug Revenue in Global Market 2018-2023
7.21.5 Kanghong Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Protein-based Drug Market Opportunities & Trends in Global Market
Table 2. Protein-based Drug Market Drivers in Global Market
Table 3. Protein-based Drug Market Restraints in Global Market
Table 4. Key Players of Protein-based Drug in Global Market
Table 5. Top Protein-based Drug Players in Global Market, Ranking by Revenue 2022
Table 6. Global Protein-based Drug Revenue by Companies, US$, Mn, 2018-2023
Table 7. Global Protein-based Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Protein-based Drug Product Type
Table 9. List of Global Tier 1 Protein-based Drug Companies, Revenue US$, Mn in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein-based Drug Companies, Revenue US$, Mn in 2022 and Market Share
Table 11. By Type – Global Protein-based Drug Revenue, US$, Mn, 2022 & 2029
Table 12. By Type - Protein-based Drug Revenue in Global US$, Mn, 2018-2023
Table 13. By Type - Protein-based Drug Revenue in Global US$, Mn, 2024-2029
Table 14. By Application – Global Protein-based Drug Revenue, US$, Mn, 2022 & 2029
Table 15. By Application - Protein-based Drug Revenue in Global US$, Mn, 2018-2023
Table 16. By Application - Protein-based Drug Revenue in Global US$, Mn, 2024-2029
Table 17. By Region – Global Protein-based Drug Revenue, US$, Mn, 2022 & 2029
Table 18. By Region - Global Protein-based Drug Revenue US$, Mn, 2018-2023
Table 19. By Region - Global Protein-based Drug Revenue US$, Mn, 2024-2029
Table 20. By Country - North America Protein-based Drug Revenue, US$, Mn, 2018-2023
Table 21. By Country - North America Protein-based Drug Revenue, US$, Mn, 2024-2029
Table 22. By Country - Europe Protein-based Drug Revenue, US$, Mn, 2018-2023
Table 23. By Country - Europe Protein-based Drug Revenue, US$, Mn, 2024-2029
Table 24. By Region - Asia Protein-based Drug Revenue, US$, Mn, 2018-2023
Table 25. By Region - Asia Protein-based Drug Revenue, US$, Mn, 2024-2029
Table 26. By Country - South America Protein-based Drug Revenue, US$, Mn, 2018-2023
Table 27. By Country - South America Protein-based Drug Revenue, US$, Mn, 2024-2029
Table 28. By Country - Middle East & Africa Protein-based Drug Revenue, US$, Mn, 2018-2023
Table 29. By Country - Middle East & Africa Protein-based Drug Revenue, US$, Mn, 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Protein-based Drug Product Offerings
Table 32. AbbVie Protein-based Drug Revenue US$, Mn & 2018-2023
Table 33. AbbVie Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Protein-based Drug Product Offerings
Table 36. Johnson & Johnson Protein-based Drug Revenue US$, Mn & 2018-2023
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Protein-based Drug Product Offerings
Table 40. Novartis Protein-based Drug Revenue US$, Mn & 2018-2023
Table 41. Novartis Key News & Latest Developments
Table 42. Gilead Sciences Company Summary
Table 43. Gilead Sciences Protein-based Drug Product Offerings
Table 44. Gilead Sciences Protein-based Drug Revenue US$, Mn & 2018-2023
Table 45. Gilead Sciences Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Protein-based Drug Product Offerings
Table 48. Roche Protein-based Drug Revenue US$, Mn & 2018-2023
Table 49. Roche Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Protein-based Drug Product Offerings
Table 52. Bristol-Myers Squibb Protein-based Drug Revenue US$, Mn & 2018-2023
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Amgen Company Summary
Table 55. Amgen Protein-based Drug Product Offerings
Table 56. Amgen Protein-based Drug Revenue US$, Mn & 2018-2023
Table 57. Amgen Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Protein-based Drug Product Offerings
Table 60. AstraZeneca Protein-based Drug Revenue US$, Mn & 2018-2023
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Merck & Co Company Summary
Table 63. Merck & Co Protein-based Drug Product Offerings
Table 64. Merck & Co Protein-based Drug Revenue US$, Mn & 2018-2023
Table 65. Merck & Co Key News & Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Protein-based Drug Product Offerings
Table 68. Takeda Protein-based Drug Revenue US$, Mn & 2018-2023
Table 69. Takeda Key News & Latest Developments
Table 70. Merck KGaA Company Summary
Table 71. Merck KGaA Protein-based Drug Product Offerings
Table 72. Merck KGaA Protein-based Drug Revenue US$, Mn & 2018-2023
Table 73. Merck KGaA Key News & Latest Developments
Table 74. Seagen Company Summary
Table 75. Seagen Protein-based Drug Product Offerings
Table 76. Seagen Protein-based Drug Revenue US$, Mn & 2018-2023
Table 77. Seagen Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Protein-based Drug Product Offerings
Table 80. Eli Lilly Protein-based Drug Revenue US$, Mn & 2018-2023
Table 81. Eli Lilly Key News & Latest Developments
Table 82. Ono Pharmaceutical Company Summary
Table 83. Ono Pharmaceutical Protein-based Drug Product Offerings
Table 84. Ono Pharmaceutical Protein-based Drug Revenue US$, Mn & 2018-2023
Table 85. Ono Pharmaceutical Key News & Latest Developments
Table 86. Pfizer Company Summary
Table 87. Pfizer Protein-based Drug Product Offerings
Table 88. Pfizer Protein-based Drug Revenue US$, Mn & 2018-2023
Table 89. Pfizer Key News & Latest Developments
Table 90. Regeneron Company Summary
Table 91. Regeneron Protein-based Drug Product Offerings
Table 92. Regeneron Protein-based Drug Revenue US$, Mn & 2018-2023
Table 93. Regeneron Key News & Latest Developments
Table 94. Innovent Company Summary
Table 95. Innovent Protein-based Drug Product Offerings
Table 96. Innovent Protein-based Drug Revenue US$, Mn & 2018-2023
Table 97. Innovent Key News & Latest Developments
Table 98. Hengrui Medicine Company Summary
Table 99. Hengrui Medicine Protein-based Drug Product Offerings
Table 100. Hengrui Medicine Protein-based Drug Revenue US$, Mn & 2018-2023
Table 101. Hengrui Medicine Key News & Latest Developments
Table 102. Sanofi Company Summary
Table 103. Sanofi Protein-based Drug Product Offerings
Table 104. Sanofi Protein-based Drug Revenue US$, Mn & 2018-2023
Table 105. Sanofi Key News & Latest Developments
Table 106. Sobi Company Summary
Table 107. Sobi Protein-based Drug Product Offerings
Table 108. Sobi Protein-based Drug Revenue US$, Mn & 2018-2023
Table 109. Sobi Key News & Latest Developments
Table 110. Kanghong Pharma Company Summary
Table 111. Kanghong Pharma Protein-based Drug Product Offerings
Table 112. Kanghong Pharma Protein-based Drug Revenue US$, Mn & 2018-2023
Table 113. Kanghong Pharma Key News & Latest Developments
List of Figures
Figure 1. Protein-based Drug Segment by Type in 2022
Figure 2. Protein-based Drug Segment by Application in 2022
Figure 3. Global Protein-based Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Protein-based Drug Market Size: 2022 VS 2029 US$, Mn
Figure 6. Global Protein-based Drug Revenue, 2018-2029 US$, Mn
Figure 7. The Top 3 and 5 Players Market Share by Protein-based Drug Revenue in 2022
Figure 8. By Type - Global Protein-based Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Protein-based Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Protein-based Drug Revenue, US$, Mn, 2022 & 2029
Figure 11. By Type - Global Protein-based Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Protein-based Drug Revenue, US$, Mn, 2022 & 2029
Figure 13. By Application - Global Protein-based Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Protein-based Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Protein-based Drug Revenue Market Share, 2018-2029
Figure 16. US Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 17. Canada Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 18. Mexico Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 19. By Country - Europe Protein-based Drug Revenue Market Share, 2018-2029
Figure 20. Germany Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 21. France Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 22. U.K. Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 23. Italy Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 24. Russia Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 25. Nordic Countries Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 26. Benelux Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 27. By Region - Asia Protein-based Drug Revenue Market Share, 2018-2029
Figure 28. China Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 29. Japan Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 30. South Korea Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 31. Southeast Asia Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 32. India Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 33. By Country - South America Protein-based Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 35. Argentina Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 36. By Country - Middle East & Africa Protein-based Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 38. Israel Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 39. Saudi Arabia Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 40. UAE Protein-based Drug Revenue, US$, Mn, 2018-2029
Figure 41. AbbVie Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 42. Johnson & Johnson Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 43. Novartis Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 44. Gilead Sciences Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 45. Roche Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 46. Bristol-Myers Squibb Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 47. Amgen Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 48. AstraZeneca Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 49. Merck & Co Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 50. Takeda Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 51. Merck KGaA Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 52. Seagen Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 53. Eli Lilly Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 54. Ono Pharmaceutical Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 55. Pfizer Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 56. Regeneron Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 57. Innovent Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 58. Hengrui Medicine Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 59. Sanofi Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 60. Sobi Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 61. Kanghong Pharma Protein-based Drug Revenue Year Over Year Growth US$, Mn & 2018-2023

Choose License Type









  Enquire Before Purchase

Have A Question ?
  Email Us


Custom Research

Still haven't found what you're looking for ?
Speak to our Custom Research Team

  Learn More

Why ProspectResearch Reports

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays



ProspectResearch Reports Logo

What our clients say